首页> 外国专利> METHYLATED MARKERS FOR ACCURATE DETECTION OF PRIMARY CENTRAL NERVOUS SYSTEM AND SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA

METHYLATED MARKERS FOR ACCURATE DETECTION OF PRIMARY CENTRAL NERVOUS SYSTEM AND SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA

机译:用于精确检测原发性中枢神经系统和全身弥漫性大B细胞淋巴瘤的甲基化标志物

摘要

Provided are methods for diagnosing and treating diffuse large B-cell lymphoma (DLBCL) and/or primary central nervous system diffuse large B-cell lymphoma (PCNSL). Provided is a set of methylation markers which were identified in silico and confirmed in archival and tissue samples could achieve 100% accuracy to discriminate DLBCL and/or PCNSL from other CNS neoplasms. The markers can be identified using QM-MSP and a simpler, faster, qMSP assay called TAM-MSP.
机译:提供了诊断和处理弥漫性大B细胞淋巴瘤(DLBCL)和/或原发性神经系统弥漫性大B细胞淋巴瘤(PCNS1)的方法。 提供了一组在硅中鉴定的一组甲基化标记,并在档案中证实,组织样品可以达到100%的精度,以区分DLBCL和/或PCNSL来自其他CNS肿瘤。 可以使用QM-MSP和更简单,更快,QMSP测定来识别标记,称为TAM-MSP。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号